The Valley Desk

NCT03329950 · Interventional trial

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Overall registry status Completed

Phase 1

Conditions Bladder Urothelial Carcinoma, Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma (DLBCL), Esophageal Cancer, Fallopian Tube Cancer, Follicular Lymphoma, Gastric Cancer, Head and Neck Cancer, Hepatic Cancer, Indolent B-cell Lymphomas, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Melanoma, Mucosa Associated Lymphoid Tissue, Non-Hodgkin Lymphoma, Non-small Cell Lung Cancer, Other Solid Tumors, Ovarian Cancer, Pancreatic Adenocarcinoma, Primary Peritoneal Cancer, Renal Cell Carcinoma, Small Lymphocytic Leukemia, Waldenstrom's Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov